IPTACOPAN ASH UPDATE

Global regulatory filings starting in H1 2023 Selected iptacopan PNH submissions FDA submission expected H1 2023 EMA submission expected H1 2023 PMDA submission expected H2 2023 Orphan Drug Designation FDA Apr. 2020, EMA Jul. 2020 Breakthrough Therapy Designation FDA Dec. 2020 24 IPTACOPAN ASH UPDATE | DECEMBER 13, 2022 China FDA submission expected H2 2023 NOVARTIS | Reimagining Medicine

View entire presentation